BlissCo Cannabis Corp Receives its Cultivars at Langley BlissCo Cannabis Corp Receives its Cultivars at its Langley Facility
Vancouver, British Columbia – May 7, 2018– BlissCo Cannabis Corp. (CSE: BLIS) is pleased to announce that the company’s wholly-owned subsidiary, Bliss Co Holdings Ltd. (“BlissCo”), has received its order of cuttings at its facility in Langley. BlissCo received the cuttings on May 2, 2018, from 7ACRES which is a Licensed Producer and wholly owned subsidiary of The Supreme Cannabis Company, Inc. (TSX.V: FIRE).
These cuttings have been proven through the 7ACRES team and bred by world-renowned seed breeders Dinafem and Paradise Seeds .
“The cuttings from 7ACRES are doing well in their new environment. We are thrilled that the plants arrived so quickly, just 34 days after BlissCo was licensed on March 29, 2018. This will enable the team to start the process to earn our sales license in an expedient manner.” said Damian Kettlewell, BlissCo CEO.
Statistics Canada estimates that Canadians spent about $5.7 billion on cannabis in 2017, despite the substance’s pending legal status.
“BlissCo has strategically acquired a range of proven CBD strains that vary from high to low CBD levels, including a 1:1 THC:CBD profile to add to our genetic library. The cannabis cultivars received by BlissCo stay true to BlissCo’s brand promise of high quality, clean and nutrient-rich dried medicinal cannabis crafted for the experience that our patients are looking for. ” added Kettlewell.
The Hemp Business Journal estimated that the global market for CBD will grow to $2.1 billion by 2020.
These cuttings will complement the four premium strains with high THC profiles which the company intends to purchase from its strategic partner The Supreme Cannabis Company, Inc . as part of a two-year, 3,000 kilogram supply agreement.
“We are seeing incredible momentum within the BlissCo team and are beginning to attract an increasing number of world-class partners and advisors who will play a key role in helping us to serve our unique customer segment. The arrival of these cultivars is just one more critical step on the way to realizing our grand vision.” added Kettlewell.
About BlissCo
BlissCo (CSE: BLIS) earned its Access to Cannabis for Medical Purposes Regulation ACMPR License to Cultivate on Thursday, March 29, 2018. BlissCo’s ACMPR facility in Langley, B.C. is designed to be a high-volume packager, processor and distributor of medical cannabis and
adult use cannabis when it is legal in Canada, which is currently anticipated to be by August 2018 at the earliest. BlissCo has a two - year supply agreement with The Supreme Cannabis Company Inc. (TSX.V: FIRE) to purchase 3,000 kilograms of premium dried cannabis.
BlissCo will apply to expand its license to cannabis oil production in Q2 2018 and will apply for its cannabis sales license at the earliest appropriate time. BlissCo will focus on high volume sales opportunities in the regulated medical use and adult use cannabis market in Canada when it is legal and is pursuing expansion opportunities in international markets.